Adenosine for refractory pulmonary hypertension

Annals of Thoracic Surgery

Volumn 62, Issue 3, 1996, Pages 874-877

  Fullerton, David A ^a   Jaggers, James ^a   Jones, Stephen D ^a   Brown, James M ^a   McIntyre Jr , Robert C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ISOPRENALINE; MILRINONE; PROSTAGLANDIN E1;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR RESISTANCE; VASODILATATION;

ADENOSINE; ADULT; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; VASODILATOR AGENTS;

EID: 0030248225     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. 1. Packer M, Greenberg B, Massie B, Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med 1982;306:1326-31.
2. 2. Klabunde RE. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 1983;93:21-6.
3. 3. Utterback DB, Staples ED, White SE, Hill JA, Belardinelli L. Basis for the selective reduction of pulmonary vascular resistance in humans during infusion of adenosine. J Appl Physiol 1994;76:724-30.
4. 4. Fullerton DA, McIntyre RC Jr, Hahn AR, et al. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am J Physiol 1995;268:L1029-35.
5. 5. McIntyre RC Jr, Harken AH, Fullerton DA. Mechanisms of pulmonary vasomotor function in normal and injured lung. Surgery 1994;115:272-5.